1. Dooley MA, Hogan SL. Environmental epidemiology and risk factors for autoimmune disease. Current Opinion Rheumatology 2003; 15: 99-103.
2. Messingham KN, Srikantha R, Degueme AM, Fairley JA. FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. Journal of Immunology 2011; 187: 553-60.
3. Winnsy S, Lonie L, Allen J, Bunce M, Marshall SE,Wojnarowska F. Genetic variation in COL17A1 and the development of bullous pemphigoid. Expect Dermatology 2004; 13: 140-7
4. Tasanen K, Tunggal L, Chometon G, Bruckner L, Aumailley M. Keratinocytes from patients lacking collagen XVII display a migratory phenotype. American Journal of Patholology 2004; 164: 2027-38
5. Chiriac MT, Licarete E, Sas AG, Rados AM, Lupan I, Chiriac AM, et al. Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice. Orphanet Journal of Rare Disesase 2013; 8: 17
6. Hiroyasu S, Ozawa T, Kobayashi H, Ishii M, Aoyama Y, Kitajima A, et al.. Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway. American Journal of Pathology 2013; 182: 828-40
7. Dimson OG, Giudice GJ, Fu CL, Vin den berg F, Warren SJ, Janson MM, et al. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. Journal of Investigation Dermatology 2003; 120: 784-8.
8. Lee IJ, Kim SC, Kim HS, Bang D, Yang WI, Jung WH, et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. Journal of American Academic Dermatology 1999; 40: 294-7
9. Barankin B, Freiman A. Misnomers in dermatology. Journal of Medical Surgery 2005; 9: 284-8.
)